Vir Combination
- Product NDC
- 43742-2123
- 11-digit product format
- 437422123
- Labeler code
- 43742
- Product ID
- 43742-2123_6bd4d4d1-1647-41de-a1bc-432a1d627106
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2022-2023)
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2024-01-25
- Marketing end
- 2029-03-20
- Substance
- HEPATITIS B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
- Active strength
- 33; 12; 12; 12; 16; 18; 15; 12; 12; 12; 12 [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Vir Combination
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HEPATITIS B VIRUS | 33 [hp_X]/mL |
| HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN | 12 [hp_C]/mL |
| HUMAN HERPESVIRUS 1 | 12 [hp_X]/mL |
| HUMAN HERPESVIRUS 2 | 12 [hp_X]/mL |
| HUMAN HERPESVIRUS 4 | 16 [hp_C]/mL |
| HUMAN HERPESVIRUS 5 | 18 [hp_X]/mL |
| HUMAN HERPESVIRUS 6 | 15 [hp_X]/mL |
| INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 12 [hp_X]/mL |
| INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 12 [hp_X]/mL |
| INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 12 [hp_X]/mL |
| INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 12 [hp_X]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 77H9EM77P7, FKD3DUK39I, 22G38P19RL, 74J6DNH49U, 2A26YW7PNX, 7COI029E6K, 4IX4VP35CR, P483J7GX6D, 34C49NV47P, TBV2PPG6EF, H2198F8ZNA |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43742-2123-1 | Vir Combination | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43742-2123 | VIR COMBINATION (ADENOVIREN NOSODE, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX VIRUS 1 DNA, HERPES SIMPLEX VIRUS 2 DNA, EPSTEIN-BARR VIRUS NOSODE, HEPATITIS B NOSODE, HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, INFLUENZINUM (2022-2023)) LIQUID [DESERET BIOLOGICALS, INC.] | 3 | Current NDC, 1 package rows | 20240829_382d5062-5da5-4fd9-a39b-367ff9d88d87.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43742-2123-1 | 43742212301 | 30 mL in 1 BOTTLE, DROPPER (43742-2123-1) | 30 ml | 2024-01-25 | 2029-03-20 | No | No | Historical |